Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus
Starting soon · Phase 1/Phase 2 · Has a placebo group
Conditions studied: Diabetic Foot, Staphylococcal Infections
In brief
The primary objective of this study is to compare the efficacy of standard treatment associated with a topical anti-staphylococcal bacteriophage cocktail versus standard treatment plus placebo for diabetic foot ulcers monoinfected by methicillin-resistant or susceptible S. aureus (MRSA or MSSA) as measured by the relative reduction in wound surface area (%) at 12 weeks.
Key facts
- Study ID
- NCT02664740
- Run by
- Centre Hospitalier Universitaire de Nīmes
- People needed
- 60
- Starts
- 2026-09-01
- Expected to finish
- 2028-11-01
- Last updated by the study team
- 2026-03-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- CHU de Bordeaux - Hôpital Pellegrin — Bordeaux, France
- CHRU de Nîmes - Hôpital Universitaire de Réadaptation du Grau du Roi — Le Grau-du-Roi, France
- Hopital européen — Marseille, France
- CHRU de Toulouse - Hôpital de Rangueil — Toulouse, France
- CH de Tourcoing — Tourcoing, France
- CH Intercommunal de Villeneuve-Saint-Georges — Villeneuve-Saint-Georges, France
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.